Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
Ambavane
V
V
Department of Pharmacology, LTM Medical College and General Hospital, Sion, Mumbai-400022, India.
Patil
R
R
Ainapure
S S
SS
D001786:Blood Glucose / Q000187:drug effects; D002219:Carbamates / Q000008:administration & dosage* / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects; D019518:Postprandial Period; D012680:Sensitivity and Specificity
D001786:Blood Glucose; D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; C072379:repaglinide